These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
166 related items for PubMed ID: 31422372
1. Cholangiolar pattern and albumin in situ hybridisation enable a diagnosis of intrahepatic cholangiocarcinoma. Brackett DG, Neyaz A, Arora K, Masia R, Mattia A, Zukerberg L, Misdraji J, Goyal L, Zhu AX, Ferrone CR, Yilmaz OH, Deshpande V. J Clin Pathol; 2020 Jan; 73(1):23-29. PubMed ID: 31422372 [Abstract] [Full Text] [Related]
2. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ferrone CR, Ting DT, Shahid M, Konstantinidis IT, Sabbatino F, Goyal L, Rice-Stitt T, Mubeen A, Arora K, Bardeesey N, Miura J, Gamblin TC, Zhu AX, Borger D, Lillemoe KD, Rivera MN, Deshpande V. Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926 [Abstract] [Full Text] [Related]
3. A Subset of Intrahepatic Cholangiocarcinomas Express Albumin RNA as Detected by In Situ Hybridization. Avadhani V, Cohen C, Siddiqui MT, Krasinskas A. Appl Immunohistochem Mol Morphol; 2021 Mar 01; 29(3):175-179. PubMed ID: 33181516 [Abstract] [Full Text] [Related]
4. Albumin In Situ Hybridization Can Be Positive in Adenocarcinomas and Other Tumors From Diverse Sites. Nasir A, Lehrke HD, Mounajjed T, Said S, Zhang L, Yasir S, Shah SS, Chandan VS, Smyrk TC, Moreira RK, Boland Froemming JM, Herrera Hernandez LP, Wu TT, Graham RP. Am J Clin Pathol; 2019 Jul 05; 152(2):190-199. PubMed ID: 31107526 [Abstract] [Full Text] [Related]
5. Decreasing Albumin mRNA Expression in Cholangiocarcinomas along the Bile Duct Tree. Albertini E, Chillotti S, Monti G, Malvi D, Deserti M, Degiovanni A, Palloni A, Tavolari S, Brandi G, D'Errico A, Vasuri F. Pathobiology; 2024 Jul 05; 91(5):338-344. PubMed ID: 38763129 [Abstract] [Full Text] [Related]
6. Utility and Limitations of Albumin mRNA In Situ Hybridization Detection in the Diagnosis of Hepatobiliary Lesions and Metastatic Carcinoma to the Liver. Collins K, Newcomb PH, Cartun RW, Ligato S. Appl Immunohistochem Mol Morphol; 2021 Mar 01; 29(3):180-187. PubMed ID: 33208670 [Abstract] [Full Text] [Related]
7. Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features. Liau JY, Tsai JH, Yuan RH, Chang CN, Lee HJ, Jeng YM. Mod Pathol; 2014 Aug 01; 27(8):1163-73. PubMed ID: 24406866 [Abstract] [Full Text] [Related]
8. Molecular and cytogenomic profiling of hepatic adenocarcinoma expressing inhibinA, a mimicker of neuroendocrine tumors: proposal to reclassify as "cholangioblastic variant of intrahepatic cholangiocarcinoma". Braxton DR, Saxe D, Damjanov N, Stashek K, Shroff S, Morrissette JD, Tondon R, Furth EE. Hum Pathol; 2017 Apr 01; 62():232-241. PubMed ID: 28232156 [Abstract] [Full Text] [Related]
9. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. Kim YH, Hong EK, Kong SY, Han SS, Kim SH, Rhee JK, Hwang SK, Park SJ, Kim TM. Oncotarget; 2016 Apr 26; 7(17):23825-36. PubMed ID: 27009864 [Abstract] [Full Text] [Related]
10. Albumin, filamin-A and cytokeratin 19 help distinguish intrahepatic cholangiocarcinoma from extrahepatic adenocarcinoma. Chung YS, Jeon Y, Yoo JE, Chung T, Ryu HJ, Kim H, Rhee H, Park YN. Hepatol Int; 2023 Feb 26; 17(1):77-85. PubMed ID: 36253584 [Abstract] [Full Text] [Related]
11. Molecular profiling of intrahepatic and extrahepatic cholangiocarcinoma using next generation sequencing. Putra J, de Abreu FB, Peterson JD, Pipas JM, Mody K, Amos CI, Tsongalis GJ, Suriawinata AA. Exp Mol Pathol; 2015 Oct 26; 99(2):240-4. PubMed ID: 26189129 [Abstract] [Full Text] [Related]
12. Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes. Xue R, Chen L, Zhang C, Fujita M, Li R, Yan SM, Ong CK, Liao X, Gao Q, Sasagawa S, Li Y, Wang J, Guo H, Huang QT, Zhong Q, Tan J, Qi L, Gong W, Hong Z, Li M, Zhao J, Peng T, Lu Y, Lim KHT, Boot A, Ono A, Chayama K, Zhang Z, Rozen SG, Teh BT, Wang XW, Nakagawa H, Zeng MS, Bai F, Zhang N. Cancer Cell; 2019 Jun 10; 35(6):932-947.e8. PubMed ID: 31130341 [Abstract] [Full Text] [Related]
13. Low-level clonal FGFR2 amplification defines a unique molecular subtype of intrahepatic cholangiocarcinoma in a Chinese population. Pu XH, Ye Q, Yang J, Wu HY, Ding XW, Shi J, Mao L, Fan XS, Chen J, Qiu YD, Huang Q. Hum Pathol; 2018 Jun 10; 76():100-109. PubMed ID: 29514108 [Abstract] [Full Text] [Related]
14. Spatial and temporal clonal evolution of intrahepatic cholangiocarcinoma. Dong LQ, Shi Y, Ma LJ, Yang LX, Wang XY, Zhang S, Wang ZC, Duan M, Zhang Z, Liu LZ, Zheng BH, Ding ZB, Ke AW, Gao DM, Yuan K, Zhou J, Fan J, Xi R, Gao Q. J Hepatol; 2018 Jul 10; 69(1):89-98. PubMed ID: 29551704 [Abstract] [Full Text] [Related]
15. S100P immunostaining identifies a subset of peripheral-type intrahepatic cholangiocarcinomas with morphological and molecular features similar to those of perihilar and extrahepatic cholangiocarcinomas. Tsai JH, Huang WC, Kuo KT, Yuan RH, Chen YL, Jeng YM. Histopathology; 2012 Dec 10; 61(6):1106-16. PubMed ID: 22882148 [Abstract] [Full Text] [Related]
16. Intrahepatic Cholangiocarcinomas Have Histologically and Immunophenotypically Distinct Small and Large Duct Patterns. Sigel CS, Drill E, Zhou Y, Basturk O, Askan G, Pak LM, Vakiani E, Wang T, Boerner T, Do RKG, Simpson AL, Jarnagin W, Klimstra DS. Am J Surg Pathol; 2018 Oct 10; 42(10):1334-1345. PubMed ID: 30001234 [Abstract] [Full Text] [Related]
17. Mucinous intrahepatic cholangiocarcinoma: a distinct variant. Chi Z, Bhalla A, Saeed O, Cheng L, Curless K, Wang HL, Patil DT, Lin J. Hum Pathol; 2018 Aug 10; 78():131-137. PubMed ID: 29698701 [Abstract] [Full Text] [Related]
18. Prognosis and Clinicopathologic Features of Patients With Advanced Stage Isocitrate Dehydrogenase (IDH) Mutant and IDH Wild-Type Intrahepatic Cholangiocarcinoma. Goyal L, Govindan A, Sheth RA, Nardi V, Blaszkowsky LS, Faris JE, Clark JW, Ryan DP, Kwak EL, Allen JN, Murphy JE, Saha SK, Hong TS, Wo JY, Ferrone CR, Tanabe KK, Chong DQ, Deshpande V, Borger DR, Iafrate AJ, Bardeesy N, Zheng H, Zhu AX. Oncologist; 2015 Sep 10; 20(9):1019-27. PubMed ID: 26245674 [Abstract] [Full Text] [Related]
19. Albumin expression distinguishes bile duct adenomas from metastatic adenocarcinoma. Moy AP, Arora K, Deshpande V. Histopathology; 2016 Sep 10; 69(3):423-30. PubMed ID: 26841202 [Abstract] [Full Text] [Related]
20. Intrahepatic cholangiocarcinoma. Nakano M, Ariizumi SI, Yamamoto M. Semin Diagn Pathol; 2017 Mar 10; 34(2):160-166. PubMed ID: 28094162 [Abstract] [Full Text] [Related] Page: [Next] [New Search]